Author

M. Gomara-Lomero

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 3 Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3

Frequent Co-Authors

J. A. Ainsa· 3 shared S. Ramon-Garcia· 3 shared A. I. Lopez-Calleja· 2 shared A. Rezusta· 2 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

J. A. Ainsa

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintJul 3, 2022

Repurposing azithromycin in combination with last-line fosfomycin, colistin and tigecycline against Multi-Drug Resistant Klebsiella pneumoniae

M. Gomara-Lomero, A. I. Lopez-Calleja, A. Rezusta…·S. Ramon-Garcia

This study evaluates azithromycin combinations with last-line antibiotics against MDR/XDR K. pneumoniae, finding synergistic effects in all tested combinations.

DOI 10.1101/2022.07.03.498633

bacteria (other)experimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintMay 17, 2022

Zidovudine multi-combos with last-line fosfomycin, ceftazidime-avibactam, colistin and tigecycline against Multi-Drug Resistant Klebsiella pneumoniae

M. Gomara-Lomero, A. I. Lopez-Calleja, A. Rezusta…·S. Ramon-Garcia

This study evaluates zidovudine-based combinations with last-line antibiotics against MDR K. pneumoniae, finding synergistic effects and potent bactericidal activity in vitro.

DOI 10.1101/2022.05.17.492182

bacteria (other)experimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintMay 16, 2022

Novel synergistic combinations of last-line antibiotics and FDA-approved drugs against Klebsiella pneumoniae revealed by in vitro synergy screenings

M. Gomara-Lomero, J. A. Ainsa, S. Ramon-Garcia

DOI 10.1101/2022.05.16.491802

bacteria (other)experimental assay

𝕏 PostBluesky